Global and United States BHK-21 Cells Market Report & Forecast 2022-2028

The most widely used line is a subclone (clone 13) of BHK21, usually called as BHK 21(C13), which has been involved in the commercial manufacture of foot and mouth disease vaccines over a twenty year period. BHK-21 cells are susceptible to multiple viruses, including human adenovirus D, reovirus 3, vesicular stomatitis virus and so on.
Market Analysis and Insights: Global and United States BHK-21 Cells Market

This report focuses on global and United States BHK-21 Cells market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global BHK-21 Cells market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, With Culture Medium accounting for % of the BHK-21 Cells global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Life Science Research was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the BHK-21 Cells market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global BHK-21 Cells Scope and Market Size

BHK-21 Cells market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global BHK-21 Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the BHK-21 Cells market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the BHK-21 Cells market is segmented into

With Culture Medium

Without Culture Medium

Segment by Application, the BHK-21 Cells market is segmented into

Life Science Research

Biopharmaceutical

Regional and Country-level Analysis

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and BHK-21 Cells Market Share Analysis

BHK-21 Cells market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in BHK-21 Cells business, the date to enter into the BHK-21 Cells market, Revenue in BHK-21 Cells Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:

Creative Biolabs

ATCC

Merck

Procell Life Science&Technology

Obio Technology

WheLab

Nanjing Cobioer Biosciences

Boster Biological Technology